TAE Life Sciences

TAE Life Sciences

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://www.taelifesciences.com

Last Round

Series C

Jun 3, 2024

Est. Valuation

$400M

Total Funding Raised

$70M

Company Overview

TAE Life Sciences is a biotechnology company focused on developing biologically targeted radiation therapies utilizing Boron Neutron Capture Therapy (BNCT) to treat invasive and challenging cancers, thereby providing patients with life-extending treatment options.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Usage-Based SaaS

AI Layer

Non-AI

Keywords

boron neutron capture therapyBNCTaccelerator-based neutron sourcetargeted boron drugstargeted radiation therapyin-hospital BNCTrecurrent cancer treatmentinoperable cancer treatmentparticle therapyradiation oncologyparticle acceleratordrug-device combinationradiopharmaceuticalshadrontherapycombination therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TAE Life Sciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TAE Life Sciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CJun 3, 2024
Series BJun 2, 2020
Series AMar 12, 2018

Key People

Founding team and executive leadership

Robert Hill

Chief Executive Officer

Executive Team

TAE Life Sciences Investors

Notable investors and investment history

InvestorRounds
Rising Tide FundSeries B, Series A
ARTIS VenturesSeries B, Series A
Big Sky PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    CNAO identified as a key deployment site.

TAE Life Sciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TAE Life Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TAE Life Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersIrvine, California
Employee Range69
Year Founded2017
Last FundingJun 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.